world-leading science programmes in nuclear and particle physics, life sciences, and materials sciences.<\/a><\/p>\nThis sustained financial support will bolster TRIUMF’s capacity to undertake pioneering research endeavours and maintain its position as a global leader in scientific exploration.<\/p>\n
Nigel Smith, TRIUMF Executive Director and CEO, commented: “The federal government has recognised the immense value of TRIUMF’s world-leading particle accelerator infrastructure, our community’s contributions to the national academic ecosystem and in training the next generation of STEM leaders, and the leadership we enable for\u00a0Canada\u00a0within international Big Science.”<\/p>\n
Empowering critical research initiatives<\/h3>\n The funding injection is poised to propel critical research and innovation efforts at TRIUMF, enabling national and international scientific communities to push the boundaries of knowledge across various disciplines.<\/p>\n
Notably, the investment will drive advancements in cancer treatment through the development of isotope-based therapies and facilitate groundbreaking explorations into the fundamental nature of the Universe using particle accelerator-produced isotopes.<\/p>\n
Focus on actinium-225 research<\/h3>\n A significant portion of the allocated funds will be dedicated to expanding research and production capabilities for actinium-225, a radioactive isotope with immense potential for cancer treatment.<\/p>\n
TRIUMF’s intensified focus on actinium-225 underscores its commitment to advancing medical science and addressing pressing healthcare challenges.<\/p>\n
Unveiling the TRIUMF Advanced Rare Isotope Laboratory<\/h3>\n TRIUMF will also inaugurate the Advanced Rare Isotope Laboratory (ARIL), a state-of-the-art facility poised to revolutionise global isotope beam science.<\/p>\n
ARIL’s establishment will triple TRIUMF’s rare isotope production capacity, fostering increased collaboration with academic, international, and industrial partners and driving innovation in the field.<\/p>\n
Angus Livingstone, Chair, TRIUMF Board of Governors, added: “With today’s budget results, the federal government is setting a strong vision for science in\u00a0Canada, and for our major science facilities and the invaluable national community of researchers who need this infrastructure to do their work.<\/p>\n
“TRIUMF is well-positioned to continue driving impact for Canadians for years and decades to come.”<\/p>\n
The substantial funding allocation for TRIUMF underscores the Canadian Government’s unwavering support for scientific excellence and collaboration.<\/p>\n
By empowering TRIUMF to expand its research capabilities and infrastructure, the investment is poised to catalyse transformative discoveries with far-reaching societal implications.<\/p>\n","protected":false},"excerpt":{"rendered":"
The Canadian Government unveiled an unprecedented investment of $399.8m in funding for TRIUMF, Canada’s esteemed particle accelerator centre.<\/p>\n","protected":false},"author":15,"featured_media":46482,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[23535,24429],"tags":[833,24555,21963,814,24578],"acf":[],"yoast_head":"\n
Canada invests $399.8m into TRIUMF particle accelerator centre<\/title>\n \n \n \n \n \n \n \n \n \n \n \n \n \n\t \n\t \n\t \n \n \n \n \n \n\t \n\t \n\t \n